Key result
p-COP software cuts contrast volume ~27% vs weight-tailored protocols in CT imaging.
Why the study?
It was unclear whether patient-specific contrast enhancement optimizer simulation software can reduce contrast material dose compared with conventional body weight-tailored protocols during TAVI-CTA in aortic stenosis patients.
Does patient-specific contrast enhancement optimizer simulation software reduce contrast material dose compared with conventional body weight-tailored scan protocol during TAVI-CTA in patients with aortic stenosis?
Cohort (n=60)
No
Does patient-specific contrast enhancement optimizer simulation software reduce contrast material dose compared with conventional body weight-tailored scan protocol during TAVI-CTA in patients with aortic stenosis?
Patient-specific contrast enhancement optimizer simulation software can safely reduce contrast material dosage and injection rates by approximately 30% during TAVI-CTA without compromising image quality.
Answers are grounded in this paper and cite their sources.
May support lower contrast dosing in TAVI-CTA without image loss; hypothesis-generating pending randomized trials.
Purpose: This study assessed whether patient-specific contrast enhancement optimizer simulation software (p-COP) can reduce the contrast material (CM) dose compared with the conventional body weight (BW)-tailored scan protocol during transcatheter aortic valve implantation-computed tomography angiography (TAVI-CTA) in patients with aortic stenosis. Methods: We used the CM injection protocol selected by the p-COP in group A (n = 30). The p-COP uses an algorithm that includes data on an individual patient’s cardiac output. Group B (n = 30) was assigned the conventional BW-tailored CM injection protocol. We compared CM dose, amount of CM, injection rates, and computed tomography (CT) value in the abdominal aorta between the two groups and classified them as acceptable (>280 Hounsfield units (HU)) or unacceptable (<279 HU) based on the optimal CT value for TAVI-CTA. Results: Group A received 56.2 ml CM and 2.6 ml/sec of injection, and group B received 76.9 ml CM and 3.4 ml/sec of injection (p < 0.01). The CT value for the abdominal aorta at the celiac level was 287.0 HU in group A and 301.7HU in group B (p = 0.46). The rate of CT value for acceptable (280 HU or more) and unacceptable (less than 280 HU) were 22 and 8 patients in group A, and 24 and 6 patients in group B, respectively (p = 0.76). Conclusion: The p-COP reduced the CM dosage, and the injection rate was approximately 30% in patients with aortic stenosis compared with the BW-tailored scan protocol during TAVI-CTA.
No takes yet. Share an insight, caveat, or question.
Masuda et al. (2023) conducted a cohort in Aortic stenosis (n=60). Patient-specific contrast enhancement optimizer simulation software (p-COP) vs. Conventional body weight (BW)-tailored scan protocol was evaluated on Amount of contrast material (mL) (p=<0.01). The p-COP software reduced the contrast material volume and injection rate compared to a conventional body weight-tailored protocol.
Synapse has enriched 10 related papers. Consider them for comparative context: